<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211028052900N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-05-01</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of topical tranexamic acid injection on bleeding during and after tonsillectomy in patients aged 15 to 45 years</public_title>
      <acronym></acronym>
      <scientific_title>The effect of topical tranexamic acid injection on bleeding during and after tonsillectomy in patients aged 15 to 45 years</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-04-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/62462</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: Randomization method is a simple randomization that is done by statistical software.  The list of patients under study is prepared in advance, which includes 20 people.
 10 people are supposed to be injected on the right side and 10 people on the left side, and in each of them placebo will be injected in the opposite side.
 Then, using random allocation software, 10 people are randomly placed in the right group and 10 people in the left group, Blinding description: The main surgeon is blind to assigning the study group. The assistant surgeon injects tranexamic acid into a patient's tonsil bed and injects distilled water into the opposite side, and the primary surgeon is unaware of the injection of tranexamic acid acid. The patient will not be informed of the side where the tranexamic acid was injected.</study_design>
      <phase>3</phase>
      <hc_freetext>TONSILECTOMY.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: 10 minutes before surgery, 100 mg of tranexamic acid is injected randomly into the bed of the right or left tonsil. The amount of intraoperative bleeding is calculated for each side of the tonsils (based on the volume of blood inside the calibrated suction and the difference in weight of blood gases before and after use, which is considered the difference in weight equal to 1 cc of blood per gram. Recovery for each side of the tonsils is performed up to 24 hours after the operation by a nursing expert who was unaware of the type of intervention drug in the patient. The score is evaluated from 0 to 10. The lowest satisfaction score is zero and the highest satisfaction score is 10 (obtained for each side of the tonsils separately). The type of surgical technique performed for all patients is cold dissection and homeostasis by suture. Intervention 2: Control group: An equal volume of distilled water is injected into the opposite side of the tonsil and the amount of bleeding during the operation for each side of the tonsil (based on the volume of blood inside the calibrated suction and the difference in weight of blood gases before and after use. Blood is considered to be calculated, and also the occurrence of bleeding in the recovery for each side of the tonsils up to 24 hours after the operation is done by a nursing expert who was unaware of the type of intervention drug in the patient. It is deducted from the volume inside the suction device. The surgeon's satisfaction is evaluated based on a score from 0 to 10, which will have the lowest satisfaction score of zero and the highest satisfaction score of 10 (which is obtained for each side of the tonsils separately). Surgery is performed for all patients with cold dissection and homeostasis by suture.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after unidentifiable individuals.

When:
Start of access period 1 month after printing the results

To whom:
The data will be available to researchers working in academic and scientific institutions.

Conditions:
Statistical analysis and the use of anonymous and unidentifiable documents will be possible after obtaining permission from the study researchers, provided by email.

Where to obtain:
It is possible to access the studies by email or by contacting the responsible researcher, Ali Badrouj.
abadrooj@gmail.com
00989140814990

How to obtain:
After submitting the request to the responsible researcher, he / she will consult with other researchers and after obtaining the opinions of other researchers, the applicant will be answered within 1 week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>ali badrooj</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezarjarib avenue</address>
        <city>isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81746-75731</zip>
        <telephone>+98 31 3620 2020</telephone>
        <email>abadrooj@gmail.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>ali badrooj</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezarjarib avenue</address>
        <city>isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81746-75731</zip>
        <telephone>+98 31 3620 2020</telephone>
        <email>abadrooj@gmail.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>15 to 45 years old
Functional class 1 and 2</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>contraindication of the use of tranexamic acid for any reason, including allergies to the drug
Anticoagulants consumption
Hematologic disorders
Uncontrolled systemic diseases
Use a catheter to control bleeding during surgery</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: 10 minutes before surgery, 100 mg of tranexamic acid is injected randomly into the bed of the right or left tonsil. The amount of intraoperative bleeding is calculated for each side of the tonsils (based on the volume of blood inside the calibrated suction and the difference in weight of blood gases before and after use, which is considered the difference in weight equal to 1 cc of blood per gram. Recovery for each side of the tonsils is performed up to 24 hours after the operation by a nursing expert who was unaware of the type of intervention drug in the patient. The score is evaluated from 0 to 10. The lowest satisfaction score is zero and the highest satisfaction score is 10 (obtained for each side of the tonsils separately). The type of surgical technique performed for all patients is cold dissection and homeostasis by suture.</i_keyword>
      <i_keyword>Control group: An equal volume of distilled water is injected into the opposite side of the tonsil and the amount of bleeding during the operation for each side of the tonsil (based on the volume of blood inside the calibrated suction and the difference in weight of blood gases before and after use. Blood is considered to be calculated, and also the occurrence of bleeding in the recovery for each side of the tonsils up to 24 hours after the operation is done by a nursing expert who was unaware of the type of intervention drug in the patient. It is deducted from the volume inside the suction device. The surgeon's satisfaction is evaluated based on a score from 0 to 10, which will have the lowest satisfaction score of zero and the highest satisfaction score of 10 (which is obtained for each side of the tonsils separately). Surgery is performed for all patients with cold dissection and homeostasis by suture.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Amount of bleeding during tonsillectomy. Timepoint: 24 hour after surgery. Method of measurement: The amount of blood collected in the suction and the change in weight of the soaked gas.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Surgeon satisfaction. Timepoint: after surgery. Method of measurement: Scale one to ten.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-03-02</approval_date>
        <contact_name>Ethics committee of Isfahan University of Medical Science</contact_name>
        <contact_address>Isfahan , Hezarjarib ave Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
